- HM&P: Vietnam International Law Firm
- HM&P: Vietnam International Law Firm
- 02873080839
- https://hmplaw.vn/
Healthcare
Current practice shows certain limitations in the current food safety management and supervision mechanism, especially the control from production, processing to circulation in the market. Recent incidents of contaminated food have raised big questions about the responsibility and management efficiency of state management agencies in controlling and supervising food safety.
In the practice of food businesses, stating the ingredients of ingredients always has many potential legal risks, although in terms of form, many brands are designed "in accordance with the law". The problem does not lie in whether the business records the composition or not, but in the way it is recorded, the level of detail and especially the ability to maintain the accuracy of the information when it is actually checked. The following are two cases of common legal risks arising in the way of recording ingredients and food labels of Vietnamese enterprises today and the direction of handling.
Intellectual property (IP) rights, especially patents, hold a unique and irreplaceable position in the global pharmaceutical and life sciences industries. This importance stems not only from the legality but also deeply ingrained in the industry's core business model, where huge research and development (R&D) costs come with a high risk of failure.
Plastic surgery is a field that combines medicine and beauty services, requiring both medical safety and flexibility to serve the needs of services in the market. However, in the current practice of Vietnamese law, the management framework is being designed in a tight but unscientific direction, leading to some difficulties in business activities and potential risks of increasing activities outside the control of the law.
Mergers and acquisitions (M&A) transactions in the pharmaceutical sector are a complex process that requires a significantly higher level of Legal Due Diligence (LDD) than in other sectors. This strictness stems from the nature of the transaction's target asset, which is primarily intangible. Besides, there is a close binding of this field with health management agencies with somewhat strict regulations. A comprehensive LDD is not just a legal requirement but a vital strategy for buyers, helping to assess risks and liabilities before making an investment in the target company.
The amended Chemical Law 2025 will take effect on January 1, 2026 with many important changes. In particular, administrative procedures will change in accordance with new regulations.
In the context of the global pharmaceutical industry restructuring after the pandemic and entering a period of outstanding biotechnology development, mergers and acquisitions (M&A) have become a strategic tool for large pharmaceutical corporations to expand their product portfolios. access to new technologies and accelerate market share. One of the notable deals in Q1 2025 is the acquisition of Checkpoint Therapeutics Inc. (USA), a pioneer in immunotherapy for skin cancer.
Compared to both the number and scale of M&A transactions in a year, Vietnam's pharmaceutical M&A market is still too small and lacks the depth of a market that develops the core of proprietary drug technology, the pharmaceutical industry – where R&D (Research and Development) products are the driving force of the market and have decisive value. to the transaction and the transaction value is in the billions of US dollars.
The cosmetics industry in Vietnam has witnessed tremendous growth in recent years, with the participation of both local businesses and international brands. However, this development also entails regulatory challenges, especially in complying with regulations on quality management and product disclosures. The announcement of a product is a mandatory legal procedure, not only for the purpose of controlling the quality of the product before putting it on the market, but also as a basis for the competent state agency to conduct an inspection after the product has been circulated.
The amended Law on Pharmacy in 2024 was approved on November 21, 2024 and takes effect from July 1, 2025, together with the Government's Decree 163/2025/ND-CP dated June 29, 2025 guiding the implementation of the Law on Pharmacy, which has introduced new regulations on drug advertising. In this article, we will clarify these new points and propose some compliance recommendations for pharmaceutical enterprises in drug advertising activities.
Proper labeling is an indispensable step when bringing cosmetics to the market. Within the scope of the article, we will provide detailed instructions on how to fully and accurately record each content on cosmetic labels according to current regulations and update some notable new points in the Draft Decree on cosmetic management in 2025 ("Draft Decree") to help businesses grasp changes and proactively adjust labels accordingly in accordance with regulations in the coming time.
In recent months, Vietnam's cosmetics industry has witnessed a series of cosmetic enterprises voluntarily revoking previously announced cosmetic product declaration forms. This shows that cosmetic businesses in Vietnam are reacting quickly to changes in the legal framework, strict management methods of competent authorities and changes in business strategies.
-
-
.png)
+84 28 7308 0839.png)
hmplaw.vn
